96373 ⎘
Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#302Galactoside inhibitors of galectins
#303Compositions and methods for treatment of disease with acetylated disaccharides
#304Aminoglycoside-polyamine displacers and methods of use in displacement chromatography
#305Peroxide removal from drug delivery vehicle
#306Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
#3076″-amino-6″-deoxygalactosylceramides
#308Structural carotenoid analogs for the inhibition and amelioration of disease
#309Production method of 2-deoxy-L-ribofuranosyl chloride compound
#310Structural family on non-ionic carbohydrate based surfactants (NICBS) and a novel process for their synthesis
#311Geranyl compounds
#312Ophthamological drugs
#313Labeled substrate conjugates for identifying enzyme inhibitors
#314Enzymatic synthesis of sugar acrylates
#315Method of fluorination
#316Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
#317Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
#318Certain aminoalkyl glucosaminide phosphate compounds and their use
#319Method of producing an amide
#320Ink jet recording material
#321Ink jet recording material
#322Carotenoid ether analogs or derivatives for controlling connexin 43 expression
#323Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#324Geranyl compounds
#325Carotenoid analogs or derivatives for the inhibition and amelioration of disease
#326Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
#327Use of mannosamine derivatives for the stimulation of neurite growth
#328Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
#329Synthetic heparin pentasaccharides
#330Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease
#331Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
#332Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#333Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
#334Carotenoid analogs or derivatives for controlling C-reactive protein levels
#335Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
#336Synthesis of beta-L-2'-deoxy nucleosides
#337Alkyl-and/or alkylene oligoglycoside betaine ester quaternaries
#338Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
#339Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
#340Use of a polyster composition as a hydraulic fluid
#341Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
#342Carotenoid analogs or derivatives for controlling expression
#343Carotenoid ester analogs or derivatives for controlling connexin 43 expression
#344Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
#345Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
#346Pharmaceutical composition comprising chito-oligomers
#347Biosynthesis of compounds in yeast